Swissmedic
REGULATORY UPDATE
EU: New GMP Implementing Regulations for Veterinary Medicinal Products
Published: 7/16/2026Detected: 7/17/2026
Summary preview
Introduces new EU implementing GMP requirements that may tighten and harmonize quality system and manufacturing expectations for veterinary medicinal products across the lifecycle.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
#GMP
#veterinary medicinal products
#EU implementing regulations
#quality management system
#manufacturing documentation
Official Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026
- Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances10/1/2026
- Revision of the Guidance document Authorisation Biosimilar10/1/2026
- Swissmedic Portal Release – New Features Available from 23 September 20269/24/2026
- I-SMI.TI.22e Notifications according to Article 41, MPLO9/23/2026